Inflammation and anti-inflammatory therapy in CVD
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Inflammation: The next therapeutic frontier in targeting cardiovascular riskThe journey from hypothesis to reality on inflammation in CVD
Paul Ridker, MD
prof. Paul Ridker, MD
- Inflammation: The next therapeutic frontier in targeting cardiovascular riskIL-6 as therapeutic target in inflammation and CVD
Paul Ridker, MD
- Inflammation: The next therapeutic frontier in targeting cardiovascular riskImmunity and inflammation in atherosclerosis - no longer just a theory
prof. Paul Ridker, MD
- Inflammation: The next therapeutic frontier in targeting cardiovascular risk3 Challenges when targeting inflammation in residual CV risk
Prof. Filippo Crea, MD
